Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

BCLI

Brainstorm Cell Therapeutics Inc.

Healthcare · USD

Set alert

Price alert · BCLI

All alert types
0.86 USD -0.05 -5.35%
As of Oct 30, 2026 Extended hours 0.67 -22.09%
Bid
1.17 × 1,000
Ask
1.18 × 2,000
0.856 Day range 0.943
0.48 52-week range 1.44
YTD
+56.38%
1 year
+32.32%
Open
0.8703
Prev close
0.90875
Mkt cap
9.49M
Vol
3.48K
Avg vol
23.42K
EPS
-0.93
P/E
0.00
Div yield
0.00%
More statistics
Low
0.856
High
0.943
Forward P/E
-0.91
Beta
0.39
Short ratio
1.25
Inst. own
13.90%
Dividend
0.00
Ex-div date
50-d avg
1.70
200-d avg
4.88
1y target
23.45

1D chart

Chart tools
Interval
1m5m15m30m
BCLI one-day price chart0.860.880.900.920.949:30 AM9:51 AM10:13 AM10:34 AM10:56 AM11:17 AM

Financial health

Altman Z-Score

-820.33 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

1 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C2 / 5 overall

  • DCF 1
  • Return on Equity 5
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 1

Valuation

P/E -0.5×
FY 2016: -9.5×FY 2017: -15.0×FY 2018: -5.3×FY 2019: -4.7×FY 2020: -4.8×FY 2021: -5.9×FY 2022: -2.5×FY 2023: -0.9×FY 2024: 1.0×FY 2025: -0.5×
FY 2016 5y median -0.9× FY 2025
P/S 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: -299×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
P/B -0.5×
FY 2016: 4.8×FY 2017: 12.6×FY 2018: 14.7×FY 2019: -9.0×FY 2020: 4.3×FY 2021: 7.5×FY 2022: -19.9×FY 2023: -3.2×FY 2024: -1.6×FY 2025: -0.5×
FY 2016 5y median -1.6× FY 2025
P/FCF -0.7×
FY 2016: -8.0×FY 2017: -29.2×FY 2018: -5.8×FY 2019: -9.3×FY 2020: -4.3×FY 2021: -5.5×FY 2022: -3.1×FY 2023: -0.8×FY 2024: -1.3×FY 2025: -0.7×
FY 2016 5y median -1.3× FY 2025
EV/EBITDA -0.5×
FY 2016: -9.6×FY 2017: -14.8×FY 2018: -5.3×FY 2019: -4.8×FY 2020: -3.9×FY 2021: -5.4×FY 2022: -2.6×FY 2023: -0.9×FY 2024: -1.1×FY 2025: -0.5×
FY 2016 5y median -1.1× FY 2025
EV/Sales 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: -304×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
FCF Yield -136.8%
FY 2016: -12.6%FY 2017: -3.4%FY 2018: -17.3%FY 2019: -10.7%FY 2020: -23.2%FY 2021: -18.3%FY 2022: -32.2%FY 2023: -130.1%FY 2024: -75.4%FY 2025: -136.8%
FY 2016 5y median -75.4% FY 2025

Profitability

Gross Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 200.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 6284.4%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 6353.3%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
ROE 100.1%
FY 2016: -50.3%FY 2017: -84.2%FY 2018: -278.1%FY 2019: 190.2%FY 2020: -89.7%FY 2021: -126.4%FY 2022: 805.2%FY 2023: 353.9%FY 2024: -149.7%FY 2025: 100.1%
FY 2016 5y median 100.1% FY 2025
ROIC 98.7%
FY 2016: -51.3%FY 2017: -85.0%FY 2018: -280.4%FY 2019: 233.3%FY 2020: -74.2%FY 2021: -100.5%FY 2022: -2302.6%FY 2023: 717.3%FY 2024: 177.2%FY 2025: 98.7%
FY 2016 5y median 98.7% FY 2025
ROA -1441.5%
FY 2016: -46.3%FY 2017: -43.4%FY 2018: -124.2%FY 2019: -355.9%FY 2020: -62.1%FY 2021: -83.5%FY 2022: -287.3%FY 2023: -408.6%FY 2024: 634.4%FY 2025: -1441.5%
FY 2016 5y median -287.3% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 100.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 FY 2025
Operating Income 14.9%
FY 2016: 40.5%FY 2017: 1.7%FY 2018: -181.3%FY 2019: -63.6%FY 2020: -37.8%FY 2021: 22.6%FY 2022: -1.2%FY 2023: 13.6%FY 2024: 45.5%FY 2025: 14.9%
FY 2016 FY 2025
EPS (diluted) -150.7%
FY 2016: 41.9%FY 2017: 2.0%FY 2018: -156.4%FY 2019: -35.7%FY 2020: -3.3%FY 2021: 28.4%FY 2022: 1.6%FY 2023: 54.9%FY 2024: 148.9%FY 2025: -150.7%
FY 2016 FY 2025
Free Cash Flow 23.3%
FY 2016: 20.0%FY 2017: 57.3%FY 2018: -401.5%FY 2019: 8.1%FY 2020: -203.5%FY 2021: 25.2%FY 2022: 27.2%FY 2023: -5.8%FY 2024: 55.6%FY 2025: 23.3%
FY 2016 FY 2025

Financial Health

Current Ratio 0.0×
FY 2016: 12.1×FY 2017: 1.7×FY 2018: 1.7×FY 2019: 0.2×FY 2020: 3.8×FY 2021: 3.7×FY 2022: 0.4×FY 2023: 0.2×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.2× FY 2025
Quick Ratio 0.0×
FY 2016: 12.1×FY 2017: 1.7×FY 2018: 1.7×FY 2019: 0.2×FY 2020: 3.8×FY 2021: 3.7×FY 2022: 0.4×FY 2023: 0.2×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.2× FY 2025
Debt / Equity -0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: -0.2×FY 2020: 0.2×FY 2021: 0.3×FY 2022: -1.4×FY 2023: -0.3×FY 2024: -0.1×FY 2025: -0.0×
FY 2016 5y median -0.1× FY 2025
Net Debt / EBITDA -0.0×
FY 2016: 0.1×FY 2017: 0.5×FY 2018: 0.1×FY 2019: -0.1×FY 2020: 1.0×FY 2021: 0.6×FY 2022: -0.1×FY 2023: 0.0×FY 2024: -0.0×FY 2025: -0.0×
FY 2016 5y median -0.0× FY 2025
Interest Coverage 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: -152×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31